SEC Filing Analysis: Elevance Health, Inc. (ELV)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Executive received annual equity compensation (RSUs and Options) and disposed of a small portion solely to cover mandatory tax withholding obligations.
• Market Impact: Neutral - This is a routine compensation event with no signal regarding market sentiment.

Company Information

Field	Value
Company	Elevance Health, Inc.
Ticker Symbol	ELV
CIK	0001156039
Industry	Hospital & Medical Service Plans

Insider Information

Field	Value
Name	Craig Ryan R
CIK	0002084547
Title/Position	EVP & Chief HR Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-03-03
Transaction Code	F (Payment of tax liability by withholding stock)
Security Type	Common Stock
Shares Involved	309 (Primary Disposition)
Price Per Share	$284.03
Total Value	$87,765
Shares Owned After	6,674
Ownership Type	Direct

Note: The filing also includes a grant of 2,976 RSUs, a grant of 11,754 Options, and a separate tax withholding of 25 shares on 2026-03-02.

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	~$95,117 (Total Tax Withholdings)
% of Market Cap	0.0001%
Shares Transacted	334 (Total Disposed)
% of Shares Outstanding	0.00015%
Post-Transaction Ownership	6,674 shares (0.003% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market capitalization of $70.63 billion, this transaction is financially immaterial.
• Ownership Concentration: The insider holds a very small fraction of the 220.7 million shares outstanding.
• Dilution Impact: The grant of ~14,730 combined equity units (RSUs + Options) represents approximately 0.006% of shares outstanding, resulting in negligible dilution.
• Transaction Significance: The transaction is purely administrative (tax withholding) and does not reflect an investment decision.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is a standard